These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34262681)

  • 41. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis.
    Guillevin L; Cordier JF; Lhote F; Cohen P; Jarrousse B; Royer I; Lesavre P; Jacquot C; Bindi P; Bielefeld P; Desson JF; Détrée F; Dubois A; Hachulla E; Hoen B; Jacomy D; Seigneuric C; Lauque D; Stern M; Longy-Boursier M
    Arthritis Rheum; 1997 Dec; 40(12):2187-98. PubMed ID: 9416856
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum soluble interleukin-2 receptor is a useful biomarker for disease activity but not for differential diagnosis in IgG4-related disease and primary Sjögren's syndrome adults from a defined population.
    Akiyama M; Sasaki T; Kaneko Y; Yasuoka H; Suzuki K; Yamaoka K; Takeuchi T
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):157-164. PubMed ID: 29465360
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum IgG4 levels at diagnosis can predict unfavorable outcomes of untreated patients with IgG4-related disease.
    Mizushima I; Konishi M; Sanada H; Suzuki K; Takeji A; Zoshima T; Hara S; Ito K; Fujii H; Yamada K; Kawano M
    Sci Rep; 2021 Jun; 11(1):13341. PubMed ID: 34172819
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increases in IgE, Eosinophils, and Mast Cells Can be Used in Diagnosis and to Predict Relapse of IgG4-Related Disease.
    Culver EL; Sadler R; Bateman AC; Makuch M; Cargill T; Ferry B; Aalberse R; Barnes E; Rispens T
    Clin Gastroenterol Hepatol; 2017 Sep; 15(9):1444-1452.e6. PubMed ID: 28223204
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relapse predictors and serologically unstable condition of IgG4-related disease: a large Chinese cohort.
    Liu Y; Zeng Q; Zhu L; Gao J; Wang Z; Wang Z; Yang F; Wang K; Chen D; Xia C; Zhang S; Wang Y; Shen D; Yu G; Li ZG
    Rheumatology (Oxford); 2020 Aug; 59(8):2115-2123. PubMed ID: 32097488
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lymphadenopathy in IgG4-related disease: a phenotype of severe activity and poor prognosis, with eotaxin-3 as a new biomarker.
    Takanashi S; Kikuchi J; Sasaki T; Akiyama M; Yasuoka H; Yoshimoto K; Seki N; Sugahara K; Chiba K; Kaneko Y; Takeuchi T
    Rheumatology (Oxford); 2021 Feb; 60(2):967-975. PubMed ID: 33167029
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of oral cyclophosphamide in the treatment of giant cell arteritis.
    Quartuccio L; Maset M; De Maglio G; Pontarini E; Fabris M; Mansutti E; Mariuzzi L; Pizzolitto S; Beltrami CA; De Vita S
    Rheumatology (Oxford); 2012 Sep; 51(9):1677-86. PubMed ID: 22627726
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients.
    Khosroshahi A; Carruthers MN; Deshpande V; Unizony S; Bloch DB; Stone JH
    Medicine (Baltimore); 2012 Jan; 91(1):57-66. PubMed ID: 22210556
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The clinical outcomes and healthcare resource utilization in IgG4-related disease: a claims-based analysis of commercially insured adults in the United States.
    Wallace ZS; Miles G; Smolkina E; Petruski-Ivleva N; Madziva D; Guzzo K; Cook C; Fu X; Zhang Y; Stone JH; Choi HK
    Rheumatology (Oxford); 2024 Sep; 63(9):2457-2466. PubMed ID: 38637947
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identifying clinical subgroups in IgG4-related disease patients using cluster analysis and IgG4-RD composite score.
    Li J; Peng Y; Zhang Y; Zhang P; Liu Z; Lu H; Peng L; Zhu L; Xue H; Zhao Y; Zeng X; Fei Y; Zhang W
    Arthritis Res Ther; 2020 Jan; 22(1):7. PubMed ID: 31924265
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of an IgG4-RD Responder Index.
    Carruthers MN; Stone JH; Deshpande V; Khosroshahi A
    Int J Rheumatol; 2012; 2012():259408. PubMed ID: 22611406
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Eurolupus cyclophosphamide plus repeated pulses of methyl-prednisolone for the induction therapy of class III, IV and V lupus nephritis.
    Ruiz-Irastorza G; Dueña-Bartolome L; Dunder S; Varona J; Gomez-Carballo C; Dominguez-Cainzos J; Rodrigo-Manjon A; Bueno L; Richez C; Duffau P; Blanco P; Lazaro E
    Autoimmun Rev; 2021 Oct; 20(10):102898. PubMed ID: 34274543
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Salivary gland involvement disparities in clinical characteristics of IgG4-related disease: a retrospective study of 428 patients.
    Liu Y; Xue M; Wang Z; Zeng Q; Ren L; Zhang Y; Zhang S; Wang Y; Shen D; Xia C; Yu G; Li ZG
    Rheumatology (Oxford); 2020 Mar; 59(3):634-640. PubMed ID: 31436287
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical features and relapse risks of IgG4-related ophthalmic disease: a single-center experience in China.
    Zhao Z; Mou D; Wang Z; Zeng Q; Wang Z; Xue J; Ren L; Liu Y; Su Y
    Arthritis Res Ther; 2021 Mar; 23(1):98. PubMed ID: 33789746
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical features of immunoglobulin G4-related disease with central nervous system involvement: an analysis of 15 cases.
    Peng L; Zhang P; Zhang X; Li J; Zhao J; Liu J; Fei Y; Zhang W; Zhu Y; Zhao Y; Zeng X
    Clin Exp Rheumatol; 2020; 38(4):626-632. PubMed ID: 32083541
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A 61-Year-Old Woman Presenting with Low Back Pain Diagnosed with IgG4-Related Disease Affecting the Thoracoabdominal Aorta and Retroperitoneum.
    Kim MR; Shim H
    Am J Case Rep; 2022 Apr; 23():e935007. PubMed ID: 35422454
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical features of patients with IgG4-related disease complicated with perivascular lesions.
    Ebe H; Tsuboi H; Hagiya C; Takahashi H; Yokosawa M; Hagiwara S; Hirota T; Kurashima Y; Takai C; Miki H; Asashima H; Umeda N; Kondo Y; Ogishima H; Suzuki T; Chino Y; Matsumoto I; Sumida T
    Mod Rheumatol; 2015 Jan; 25(1):105-9. PubMed ID: 24754274
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Coronary artery wall contrast enhancement imaging impact on disease activity assessment in IgG4-RD: a direct marker of coronary involvement.
    Du Y; Ding S; Li C; Bai Y; Wang X; Li D; Xie Y; Fan G; Wu LM; Wang G
    J Cardiovasc Magn Reson; 2024 May; 26(2):101047. PubMed ID: 38825155
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of immunoglobulin G4-related sialadenitis: outcomes of glucocorticoid therapy combined with steroid-sparing agents.
    Hong X; Zhang YY; Li W; Liu YY; Wang Z; Chen Y; Gao Y; Sun ZP; Peng X; Su JZ; Cai ZG; Zhang L; He J; Ren LM; Yang HY; Li ZG; Yu GY
    Arthritis Res Ther; 2018 Jan; 20(1):12. PubMed ID: 29382364
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical and laboratory characteristics of IgG4-realated disease and its diagnostic algorithm].
    Sokol EV; Vasilyev VI; Palshina SG; Kokosadze NV; Probatova NA; Kovrigina AM; Safonova TN; Rodionova EB; Gaiduk IV; Selifanova EI
    Ter Arkh; 2019 May; 91(5):40-48. PubMed ID: 32598675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.